NCT02844634View on ClinicalTrials.gov

Tenofovir/Emtricitabine With Doxycycline for Combination HIV and Syphilis Pre-exposure Prophylaxis in HIV-negative MSM

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

May 15, 2018

Primary Completion Date

May 28, 2020

Study Completion Date

September 7, 2022

Conditions
HIVSyphilis
Interventions
DRUG

Doxycycline 100mg PO daily x 12 months

Immediate use of daily doxycycline (12 months duration, to start immediately)

DRUG

Tenofovir/emtricitabine 200/300mg PO daily

Daily use of tenofovir/emtricitabine

DRUG

Doxycycline 100mg PO daily x 6 months

Deferred use of doxycycline (6 months duration, to start 6 months post-randomization)

Trial Locations (1)

V5Z4R4

BC Centre for Disease Control, Vancouver

All Listed Sponsors
lead

British Columbia Centre for Disease Control

OTHER_GOV

NCT02844634 - Tenofovir/Emtricitabine With Doxycycline for Combination HIV and Syphilis Pre-exposure Prophylaxis in HIV-negative MSM | Biotech Hunter | Biotech Hunter